Joe Goldstein and Mike Brown: From cholesterol homeostasis to new paradigms in membrane biology

Trends in Cell Biology

Volumn 13, Issue 10, 2003, Pages 534-539

  Anderson, Richard G W ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

CELL MEMBRANE; CELL METABOLISM; HOMEOSTASIS; HUMAN; INTRACELLULAR SPACE; LIPID BILAYER; MEMBRANE BIOLOGY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW;

ANIMALS; BIOCHEMISTRY; CCAAT-ENHANCER-BINDING PROTEINS; CELL MEMBRANE; CHOLESTEROL; DNA-BINDING PROTEINS; HISTORY, 20TH CENTURY; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PORTRAITS; PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; UNITED STATES;

EID: 1542713799     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2003.08.007     Document Type: Review

References (30)

1. Foster D.W., Wilson J.D. Presentation of the Kober Medal to Joseph L. Goldstein and Michael S. Brown. J. Clin. Invest. 110:2002;S5-S9.
2. Goldstein J.L., Brown M.S. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc. Natl. Acad. Sci. U. S. A. 70:1973;2804-2808.
3. Goldstein J.L., et al. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. U. S. A. 71:1974;4288-4292.
4. Goldstein J.L., Brown M.S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249:1974;5153-5162.
5. Anderson R.G., et al. Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts. Cell. 10:1977;351-364.
6. Roth T.F., Porter K.R. Yolk protein uptake in the oocyte of the mosquito Aedes aegypti L. J. Cell Biol. 20:1964;313-332.
7. Fawcett D.W. Surface specializations of absorbing cells. J. Histochem. Cytochem. 13:1965;75-91.
8. Pearse B.M. Clathrin: a unique protein associated with intracellular transfer of membrane by coated vesicles. Proc. Natl. Acad. Sci. U. S. A. 73:1976;1255-1259.
9. Anderson R.G., et al. A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts. Nature. 270:1977;695-699.
10. Davis C.G., et al. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell. 45:1986;15-24.
11. Goldstein J.L., et al. Familial hypercholesterolemia. Valle D. The Metabolic & Molecular Bases of Inherited Disease. Vol. 2:2001;2863-2914 McGraw-Hill.
12. Pathak R.K., et al. Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice. J. Cell Biol. 111:1990;347-359.
13. Garcia C.K., et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 292:2001;1394-1398.
14. Yokoyama C., et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75:1993;187-197.
15. Reiss Y., et al. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell. 62:1990;81-88.
16. Chen W.J., et al. cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransferase, the counterpart of yeast DPR1/RAM1. Cell. 66:1991;327-334.
17. James G.L., et al. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells. J. Biol. Chem. 269:1994;27705-27714.
18. Schmidt R.A., et al. Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J. Biol. Chem. 259:1984;10175-10180.
19. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:1997;331-340.
20. Brown M.S., et al. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell. 100:2000;391-398.
21. Goldstein J.L., et al. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch. Biochem. Biophys. 397:2002;139-148.
22. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11041-11048.
23. Nohturfft A., et al. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell. 102:2000;315-323.
24. Rothberg K.G., et al. Caveolin, a protein component of caveolae membrane coats. Cell. 68:1992;673-682.
25. Rothberg K.G., et al. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 111:1990;2931-2938.
26. Brown A.J., et al. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol. Cell. 10:2002;237-245.
27. Yang T., et al. Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP.SREBP exit from endoplasmic reticulum. J. Biol. Chem. 275:2000;29881-29886.
28. Yang T., et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell. 110:2002;489-500.
29. Sever N., et al. Accelerated degradation of HMG-CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol. Cell. 11:2003;25-33.
30. Brown M.S., Goldstein J.L. Receptor-mediated control of cholesterol metabolism. Science. 191:1976;150-154.